Skip to content
ClinCalc Pro
Menu
Opioid + NSAID combination

Tramadol with dexketoprofen

Brand names: Skudexa

A fixed-dose oral combination of the opioid analgesic tramadol with the NSAID dexketoprofen, used for short-term treatment of moderate to severe acute pain. This page covers the combination tablet and its dual analgesic risks.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Tramadol is a weak mu-opioid agonist that also inhibits serotonin and noradrenaline reuptake, while dexketoprofen inhibits cyclo-oxygenase to reduce prostaglandin-mediated pain and inflammation; the two provide complementary analgesia.

Prescribing in practice

  • Combine NSAID and opioid hazards — the dexketoprofen component carries gastrointestinal, renal and cardiovascular risks while tramadol carries respiratory depression, dependence and seizure risk, so use the lowest effective dose for the shortest time.
  • Tramadol lowers the seizure threshold and can cause serotonin syndrome, so avoid with other serotonergic drugs and in those with epilepsy.
  • Avoid in active peptic ulceration, significant renal impairment and where NSAIDs or opioids are contraindicated, and limit to short courses.

Monitoring

Monitor pain control, sedation and respiratory status, and watch for gastrointestinal and renal adverse effects during use.

Counselling the patient

  • Take with or after food and only for short-term pain as directed.
  • Avoid alcohol and report black stools, indigestion or excessive drowsiness.
  • Do not take other NSAID or paracetamol-opioid products at the same time without advice.

Evidence & guidelines

The combination is supported by acute-pain trials demonstrating additive analgesia, with safety framed by established NSAID and opioid class data.

Reference: NICE; SmPC; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.